• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Carryover Balances (FY 2010)

Back to Table of Contents: FY2010 ADUFA Financial Report

 

Under ADUFA, fees collected, appropriated, and not obligated at the end of a fiscal year remain available to the FDA in future fiscal years. These funds are referred to as carryover balances. The operations in FY 2010 resulted in a net decrease of the carryover balance of $785,398, from $4,013,835 to $3,228,437.

 
TABLE 3
Statement of Animal Drug User Fee Collections,
obligations, and carryover Balances by Fiscal Year
As of September 30, 2010
 
Fiscal
Year
Beginning
Carryover
Net
Collection
Obligation
Year-End
Carryover
2004
-
$4,866,475
$1,083,300
$3,783,175
2005
$3,783,175
$8,301,551
$8,489,000
$3,595,726
2006
$3,595,726
$11,017,828
$9,675,678
$4,937,876
2007
$4,937,876
$13,471,861
$12,270,000
$6,139,736
2008
$6,139,736
$11,420,145
$13,530,069
$4,029,812
2009
$4,029,812
$13,363,223
$13,379,200
$4,013,835
2010
$4,013,835
 $15,815,302
$16,600,700
 $3,228,437
2011
$3,228,437
 
 
 
Numbers may not add due to rounding to the nearest dollar.
 
Please note that the balances in Table 3 reflect the cumulative cash from the beginning to the end of each fiscal year, and net cash collected during each fiscal year for all cohort years. The numbers do not include any accounts receivable. Therefore these numbers for FY 2009 and FY 2010 are different from the numbers on page 3, which reflect total net collections for the cohort years only.
 
Collections Ceilings and Surplus
 
Under ADUFA II, if cumulative collections through FY 2011, including an estimate for FY 2012, exceed the fee revenue amounts specified in the Appropriations Acts for that period, FDA will reduce the fee rates for FY 2013 by the cumulative amount that fees exceeded the appropriations during that period. The beginning total for the offset includes any remaining ADUFA I collections that were collected after the final adjustment was made when fees were set for FY 2010. Table 4 depicts FY 2010 fee collections realized (the same as Total Collections in the table on page 3), collection ceilings specified in the Appropriations Act, and amounts that must be set aside to be used to offset future collections.
 
 
TABLE 4
Statement of Animal Drug User Fees Collected, Collections
Ceiling, and Amounts to Offset Future Collections
As of September 30, 2010
 
Fiscal
Year
Collections Realized
Collection Ceiling
Amount to Offset Future Collections
2004
$5,154,700
$5,000,000
$154,700
2005
$8,519,101
$8,354,000
$165,101
2006
$10,901,466
$11,318,000
$0
2007
$13,342,455
$11,604,000
$1,738,455
2008
$11,543,034
$13,696,000
$0
ADUFA I TOTAL
$2,058,256
2009
$12,825,555
$15,260,000
($2,434,445)
2010
$15,945,437
$17,280,000
($1,334,563)
 
 
ADUFA II TOTAL :
($3,769,008)
Amount Offset When Fees for FY 2008 Were Determined:
$320,000
Amount Offset When Fees for FY 2009 Were Determined:
$1,344,000
Amount Offset When Fees for FY 2010 Were Determined:
$0
Balance to be Offset in a Subsequent Fiscal Year
$394,256
 
As discussed earlier on page 3, previous cohort year collections realized in FY 2009 have been updated from last year’s report. The update reflects net collections for each cohort year through September 30, 2010. Any and all cohort year fees collected subsequent to September 30, 2010 will be reported in the FY 2011 financial report.
 
Reserves and Balance Available for Allocation
 
Table 5 provides a summary of carryover balances as of September 30, 2010, and anticipated claims on those balances.
 
The first anticipated claim is the reserve for future offsets of $394,256 shown above. In addition, prudent operations require that a reserve be kept aside for other potential refunds. For that purpose a total of $500,000 is being set aside. That leaves a total of $2,334,181 available for allocation. This amount will fund about 1.4 months of estimated FY 2011 operations from user fee revenue.
 
  
TABLE 5
Summary Statement of Carryover Balance
As of September 30, 2010
 
Amount
Reserve for Future Collection Offset
$394,256
Reserve for Refunds
$500,000
Available for Allocation
$2,334,181
TOTAL Carryover Balance
$3,228,437

 
Next Section: Total Cost of the Process for the Review of Animal Drug Applications